Purpose Most patients with advanced ovarian cancer develop recurrent disease. For those
patients who recur at least 6 months after initial therapy, paclitaxel platinum has shown a …

Multimorbidity is a health issue mostly dealt with in primary care practice. As a result of their
generalist and patient-centered approach, long-lasting relationships with patients, and …

Background Student’s two-sample t test is generally used for comparing the means of two
independent samples, for example, two treatment arms. Under the null hypothesis, the t test …

OBJECTIVE: Ovarian cancer outcome varies among different institutions, regions, and countries.
This systematic review summarizes the available data evaluating the impact of different …

PURPOSE We wanted to determine the effect of promoting the effective communication of
absolute cardiovascular disease (CVD) risk and shared decision making through …

Purpose Despite the progress that has been achieved, long-term survival rates in patients
with advanced ovarian cancer are still disappointing. One attempt to improve results could be …

Background The potential anti-cancer effects of mammalian target of rapamycin (mTOR)
inhibitors are being intensively studied. To date, however, few randomised clinical trials (RCT) …

Introduction The HER (human EGFR related) family of receptor tyrosine kinases (HER1/EGFR
(epidermal growth factor receptor)/c-erbB1, HER2/c-erbB2, HER3/c-erbB3 and HER4/c-…

The purpose of this study was to evaluate the pattern and quality of care for ovarian cancer
in Germany and analyze prognostic factors with emphasis on characteristics of treating …

Objectives Investigate the effectiveness of a complex intervention aimed at improving the
appropriateness of medication in older patients with multimorbidity in general practice. Design …